ZNF263-mediated LINC00599 transcriptional regulation

Exploratory Score: 0.800 Price: $0.50 Pulmonary hypertension Cell-based transcriptional assays Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting LINC00599 in Cell-based transcriptional assays. Primary outcome: LINC00599 transcriptional activity

Description

This study investigated the upstream regulation of LINC00599 expression and identified that its transcription is driven by a super-enhancer mediated by the transcription factor ZNF263. The research examined the regulatory mechanisms controlling LINC00599 expression levels, which is important for understanding how this long noncoding RNA becomes upregulated in pulmonary hypertension. The identification of ZNF263 as a key transcriptional regulator provides insight into the hierarchical control of LINC00599 expression and suggests additional potential therapeutic targets in the regulatory pathway.

TARGET GENE
LINC00599
MODEL SYSTEM
Cell-based transcriptional assays
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
Transcriptional regulation via super-enhancer
SOURCE
extracted_from_pmid_40693377
PRIMARY OUTCOME
LINC00599 transcriptional activity

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

📖 Wiki Pages

RNA Interference (RNAi) Therapies for NeurodegenertherapeuticRNA-Based Therapeutics for Neurodegenerative DiseatherapeuticRNA Targeting Therapy for NeurodegenerationtherapeuticRNA-Targeting Therapies for Neurodegenerative DisetherapeuticRNA-Based Therapeutics for Alzheimer's DiseasetherapeuticRNA Editing TherapeuticstechnologyRNA Toxicity PathwaymechanismRNA-Targeted Therapeutics Investment SynthesismechanismRNA-Targeted Therapies in NeurodegenerationmechanismRNA Stability and DecaymechanismRNA Splicing Defects in NeurodegenerationmechanismRNA Splicing Dysregulation in 4R-Tauopathies: A ComechanismRNA Splicing in NeurodegenerationmechanismRNA Processing in NeurodegenerationmechanismRNA Metabolism Dysregulation Pathwaymechanism

Protocol

Analysis of ZNF263-mediated super-enhancer regulation of LINC00599 transcription

Expected Outcomes

ZNF263 drives LINC00599 expression through super-enhancer mechanism

Success Criteria

Demonstration of ZNF263-dependent LINC00599 transcriptional activation

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.